Investors & Partners
BarclaysGate Ltd presents NeuroCare: a deep tech solution bridging medical precision and AI to transform home-based geriatric support. We are setting a new standard for clinical safety and dignified independence.
Our partnership process: 1) Register your interest. 2) Explore tailored options and access details for our €2,000,000 Deep Tech funding round.
Our Global Care Platform
Our integrated platform supports scalable home care operations with multi-market clinical compliance and high availability.
Platform at a glance
- Global platform with local site presence
- Centralized data, reporting, and governance
- Role-based access for strategic oversight
- Rapidly scalable across markets and currencies
- Optimized for geriatric and future health services
Secure Governance
Centralized infrastructure for data and care plans with full auditability and transparent clinical oversight.
Local Expertise
Clinical experts led regional operations, aligning global tech with local clinical networks.
Scalable Architecture
Flexible core designed for rapid market entry and seamless partner integration.
Deep Tech Summary
Project Title
NeuroCare: AI-Driven Clinical Coordination (2025–2028).
Executive Summary
A €2M initiative to transform home care via robotic assistance and real-time clinical monitoring.
Impact
NeuroCare enhances home safety with clinical-grade monitoring, significantly reducing hospital readmission rates and pressure on public health systems. By establishing specialized clinical and technical hubs, the initiative creates high-value skilled jobs across both health and technology sectors.
Company
BarclaysGate Ltd (t/a Med Clinic Care): 20+ years of healthcare excellence meets next-gen health tech.
Problem
Current home care often lacks clinical precision, real-time monitoring, and structured escalation. Families and providers struggle to spot early risk and intervene before a crisis. Health systems face rising costs and pressure because issues are caught too late.
Solution
NeuroCare combines nursing oversight, AI and assistive robotics to monitor safety in the home. The system flags early risk, supports structured escalation, and guides caregivers with clear protocols. This turns home care visits into a coordinated, data-informed safety net around each person.
Opportunity
Tapping into Europe's silver economy with a high-trust, tech-enabled geriatric support model.
Innovation
Proprietary AI and assistive robotics integrated directly into specialized care pathways.
Use of Funds
The €2M funding will accelerate R&D for V2 robotics and medical-grade AI core. Resources will support clinical hub expansion and operational scaling for broader support. Capital is allocated for strategic market entry and pilot launches in priority countries.
Timeline
In 2025, we will complete key engineering milestones, regulatory certification, and initial market pilots. During 2026–27, focus shifts to scaling therapeutic services across multiple European regions. Future phases involve full platform optimization and expansion into high-growth international markets.
Leadership
NeuroCare is led by Clinical Director Dr. Sarah Thompson alongside a management team with 20+ years in home care and health technology. Their combined expertise in clinical governance and digital transformation ensures the necessary oversight to scale NeuroCare across global markets. This leadership brings the high-trust clinical authority required to define new safety standards in home-based geriatric support.
Social Impact
Reducing public health burden and empowering seniors to maintain independence safely at home.
Funding Round
We are inviting strategic health, technology and impact investors to join our €2M funding round. This capital supports our current clinical validation stage, enabling us to scale a new standard for home-based coordination. Together, we will define a future where clinical safety and dignified independence are seamlessly integrated in the home.
Strategic Highlights
Market Scalability
Pan-European expansion via scalable tech framework.
Early Advantage
Securing prime position in home health tech nexus.
Technology Stack
AI diagnostics and robotics for real-time safety.
Job Creation
Specialized roles across clinical and technical hubs.
Regulatory Alignment
HIPAA and EU health regulation compliant.
Authority
Backed by BarclaysGate clinical expertise.
Strategic Growth
Partnership Models
Equity Investment
Direct contribution to our €2M round for a significant stake in a high-growth venture.
Strategic Partnership
Collaborative development for providers integrating AI and robotics into their value chain.
Co-funded Pilots
Joint innovation initiatives to test NeuroCare applications in real-world clinical settings.
Investor Interest
Register below to begin our formal partnership discovery process.
NAME
ORGANIZATION
INVESTMENT INTEREST LEVEL
Select interest level...
MESSAGE